We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

571 hedge funds and large institutions have $1.18B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2020 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 120 increasing their positions, 186 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,672% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $560K

9% less first-time investments, than exits

New positions opened: 68 | Existing positions closed: 75

2% less funds holding

Funds holding: 583 → 571 (-12)

9% less funds holding in top 10

Funds holding in top 10: 11 → 10 (-1)

35% less repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 186

37% less capital invested

Capital invested by funds: $1.89B → $1.18B (-$706M)

Holders
571
Holders Change
-12
Holders Change %
-2.06%
% of All Funds
11.52%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.2%
New
68
Increased
120
Reduced
186
Closed
75
Calls
$15.5M
Puts
$560K
Net Calls
+$15M
Net Calls Change
-$8.18M

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$48.3M
2
NCM
Nantahala Capital Management
Connecticut
+$44.1M
3
LCM
Laurion Capital Management
New York
+$22.1M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$20.3M
5
MP
Mangrove Partners
Connecticut
+$17.5M

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$44.2M
2
BCM
Beryl Capital Management
California
-$27.6M
3
ACM
Abrams Capital Management
Massachusetts
-$24M
4
EC
EcoR1 Capital
California
-$17M
5
Marshall Wace
Marshall Wace
United Kingdom
-$15.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
LFG
451
Larson Financial Group
Missouri
$3K – – –
LDFR
452
Lehman & Derafelo Financial Resources
Pennsylvania
$3K – – –
MFT
453
Moisand Fitzgerald Tamayo
Florida
$3K – – –
BAM
454
Barrett Asset Management
New York
$3K +$206 +72 +6%
TF
455
TimeScale Financial
Massachusetts
$3K +$2.78K +974 New
EI
456
Ellevest Inc
New York
$3K +$3.57K +1,250 New
EWM
457
Endurance Wealth Management
Rhode Island
$3K +$3.71K +1,300 New
ACM
458
AUA Capital Management
Pennsylvania
$3K +$4.28K +1,500 New
AWA
459
Arkadios Wealth Advisors
Georgia
$2.42K – – –
CLOS
460
Compagnie Lombard Odier SCmA
Switzerland
$2K -$3.88K -1,360 -69%
BC
461
Barnett & Company
Tennessee
$2K -$3.43K -1,200 -58%
AssetMark Inc
462
AssetMark Inc
California
$2K -$1.01K -354 -28%
AWM
463
Aberdeen Wealth Management
Illinois
$2K – – –
ADL
464
Asset Dedication LLC
California
$2K – – –
CHA
465
Carmichael Hill & Associates
Maryland
$2K – – –
DWA
466
Dougherty Wealth Advisers
Minnesota
$2K – – –
FFW
467
Fusion Family Wealth
New York
$2K – – –
GRP
468
Global Retirement Partners
California
$2K – – –
PFO
469
Pathstone Family Office
New Jersey
$2K – – –
RWB
470
RMR Wealth Builders
New Jersey
$2K – – –
SIM
471
Sentry Investment Management
Wisconsin
$2K – – –
BWP
472
Baldwin Wealth Partners
Massachusetts
$2K +$500 +175 +23%
WT
473
Washington Trust
Rhode Island
$2K +$1K +350 +65%
AA
474
Advisory Alpha
Michigan
$2K +$1.78K +625 New
KCM
475
Kathmere Capital Management
Pennsylvania
$2K +$2.45K +858 New
17 18
19
20 21

BMY.RT Hedge Fund Activity: Q3 2020 in Review

571 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q3 2020, worth a combined $1.18B — down 37% from $1.89B a quarter earlier.

Sellers outnumbered buyers: 75 funds closed out of BMY.RT and 68 opened new positions — a net loss of 7 holders — while 186 trimmed existing stakes and 120 added.

The largest buyer was Avidity Partners Management, adding an estimated $48.3M. The largest seller was Pentwater Capital Management, cutting an estimated $44.2M.

  • 571 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q3 2020, down from 583 in Q2 2020.
  • Funds reported $1.18B of Bristol-Myers Squibb Company Contingent Value Rights stock for Q3 2020, down 37% quarter-over-quarter.
  • 68 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q3 2020 and 75 closed out, a net change of -7 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q3 2020 was Avidity Partners Management, an estimated $48.3M added.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q3 2020 was Pentwater Capital Management, an estimated $44.2M sold.

Based on aggregated 13F filings for Q3 2020.